文档介绍：不同剂量阿托伐他汀治疗心梗后无症状心衰患者的临床疗效比较
 
   
 
 
 
 
 
 
 
     
 
 
 
 
 
【摘要】目的 研究分析不同剂量阿托伐他汀治疗心梗后无症状心衰的疗效比较。方法 此次研究的对象是选择2018年12月至2020年3月在我院接受治疗的心梗后无症状心衰患者102例，将其临床进行回顾性分析，并随机将其分成对照组51例，观察组51例，对照组采用20 mg的阿托伐他汀治疗，观察组采用40 mg的阿托伐他汀治疗，对比两组患者接受治疗后心功能指标的情况，并记录观察两组患者的超敏C-反应蛋白和血浆BNP水平。结果 经过治疗后，观察组患者的心功能指标、超敏C-反应蛋白和血浆BNP水平均明显优于对照组患者（P<）。结论 和采用每天20 mg的剂量相比，每天给予患者40 mg阿托伐他汀更有利于缓解患者的症状，因此值得临床推广应用。  【关键词】阿托伐他汀；心肌梗死；无症状心衰；治疗效果  [Abstract] Objective To study and analyze the efficacy of different doses of atorvastatin in the treatment of asymptomatic heart failure after myocardial infarction. Methods 102 patients with asymptomatic heart failure after myocardial infarction in our hospital from December 2018 to March 2020 were selected and randomly pided into control group (51 cases) and observation group (51 cases). The control group was treated with 20 mg atorvastatin and the observation group was treated with 40 mg atorvastatin After atorvastatin treatment, the cardiac function indexes of the two groups were compared, and the levels of high-sensitivity C-reactive protein and plasma BNP were recorded and observed. Results after treatment, the cardiac function index, high sensitivity C-reactive protein and plasma BNP levels in the observation group were significantly better than those in the control group (P < ). Conclusion compared with the dosage of 20 mg per day, at